Generation Bio Co Asset Turnover Ratio (GBIO), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Generation Bio Co   (NASDAQ: GBIO)
 

Generation Bio Co Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Generation Bio Co 's asset turnover ratio, the ratio that measures the ability of Generation Bio Co 's assets to generate revenue, sequentially decreased to 0.08 in the third quarter (Sep 30 2025), but it does not raise any concerns as Generation Bio Co continue to execute well, and the asset turnover ratio remains above the average.

Within sector 158 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2025 compared to the preceding quarter from 2743 to 3059.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GBIO Asset Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Asset Change -51.15 % -32.6 % -30.11 % -37.93 % -34.77 %
Y / Y Revenue Change -78.9 % -81.3 % 114.91 % 45.52 % 252 %
Asset Turnover Ratio (TTM) 0.08 0.1 0.1 0.08 0.06
GBIO's Total Ranking # 3059 # 2743 # 2975 # 2838 # 2325
Seq. Asset Change -32.33 % -10.9 % -13.31 % -6.54 % -6.63 %
Seq. Revenue Change 108.37 % -91.23 % 108.29 % -44.56 % 84.65 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 159
Healthcare Sector # 465
Overall Market # 3059

Asset Turnover Ratio Statistics
High Average Low
0.1 0.07 0.03
(Mar 31 2025)   (Mar 31 2024)




GBIO Company Profile • Back to GBIO Efficiency Comparisons • Compare GBIO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Dynavax Technologies Corporation  0.35 $ 330.513  Millions$ 949.285  Millions
Elanco Animal Health Incorporated  0.35 $ 4,591.000  Millions$ 13,212.000  Millions
Veracyte Inc   0.34 $ 455.937  Millions$ 1,331.834  Millions
Amarin Corp Plcuk  0.34 $ 226.734  Millions$ 667.742  Millions
Curis Inc   0.34 $ 11.650  Millions$ 34.367  Millions
Vanda Pharmaceuticals Inc   0.34 $ 212.074  Millions$ 628.507  Millions
Krystal Biotech Inc   0.33 $ 373.165  Millions$ 1,127.186  Millions
The Cooper Companies Inc   0.33 $ 4,092.100  Millions$ 12,375.075  Millions
Mersana Therapeutics inc   0.33 $ 33.180  Millions$ 101.098  Millions
Celularity Inc   0.33 $ 40.578  Millions$ 124.020  Millions
Prestige Consumer Healthcare Inc   0.33 $ 1,109.969  Millions$ 3,398.635  Millions
Arvinas Inc   0.32 $ 312.300  Millions$ 961.525  Millions
Geron Corporation  0.32 $ 182.904  Millions$ 569.703  Millions
Quanterix Corporation  0.32 $ 130.090  Millions$ 405.698  Millions
Ionis Pharmaceuticals Inc   0.32 $ 944.052  Millions$ 2,970.714  Millions
Zymeworks Inc   0.32 $ 134.481  Millions$ 423.567  Millions
Intelligent Bio Solutions Inc   0.32 $ 3.292  Millions$ 10.413  Millions
Regenxbio Inc   0.31 $ 161.318  Millions$ 515.787  Millions
Utah Medical Products Inc  0.31 $ 37.895  Millions$ 121.959  Millions
Opko Health Inc   0.31 $ 642.066  Millions$ 2,074.259  Millions
Arcturus Therapeutics Holdings Inc   0.31 $ 97.600  Millions$ 316.867  Millions
Scilex Holding Company  0.30 $ 40.360  Millions$ 132.891  Millions
Pfizer Inc  0.30 $ 62,785.000  Millions$ 209,062.500  Millions
Butterfly Network Inc   0.30 $ 88.250  Millions$ 294.444  Millions
Cyclerion Therapeutics Inc   0.29 $ 2.855  Millions$ 9.802  Millions
Tenon Medical Inc   0.29 $ 3.233  Millions$ 11.179  Millions
Protagonist Therapeutics inc   0.29 $ 209.217  Millions$ 726.638  Millions
Xilio Therapeutics Inc   0.29 $ 31.804  Millions$ 110.574  Millions
Nutriband Inc   0.28 $ 2.278  Millions$ 8.054  Millions
Liquidia Corporation  0.28 $ 69.216  Millions$ 247.783  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.